<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085438/" ref="ordinalpos=2343&amp;ncbi_uid=3383904&amp;link_uid=PMC3085438" image-link="/pmc/articles/PMC3085438/figure/F5/" class="imagepopup">Fig. 5. From: CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor <span class="highlight" style="background-color:">signaling</span> in breast cancer. </a></div><br /><div class="p4l_captionBody"><b>Working model for the role of CCN6 in breast cancer invasion.</b> Our data support the hypothesis that CCN6 regulates the levels and activity of IGF-1R signaling pathway in mammary epithelial cells. Low levels of CCN6, as found in aggressive invasive carcinomas of the breast, result in activation of IGF-1R signaling and increased ZEB1 levels and function.</div></div>